Clinical Trial Detail


Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at :

NCT ID NCT03438396
Title A Trial of Tisotumab Vedotin in Cervical Cancer
Recruitment Completed
Gender female
Phase Phase II
Variant Requirements No
Sponsors Genmab

cervical squamous cell carcinoma

cervical adenocarcinoma

cervical adenosquamous carcinoma


Tisotumab vedotin-tftv

Age Groups: senior | adult
Covered Countries USA | ITA | ESP | DEU | BEL

No variant requirements are available.